Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance

NCT: NCT07020637 · RECRUITING

NCT IDNCT07020637
StatusRECRUITING
Start Date2024-10-19
Completion2026-04-30

Brief Summary

This study aims to evaluate the correlation between stroke volume measurements obtained by transthoracic echocardiography and bioreactance-based noninvasive cardiac output monitoring. The primary objective is to assess the level of agreement between these two modalities in critically ill patients.

Frequently Asked Questions

What is Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance?

Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance is a clinical trial registered under NCT07020637. Current status: RECRUITING.

What is the status of NCT07020637?

The current status of NCT07020637 (Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance) is: RECRUITING.

When did Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance start?

Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance started on 2024-10-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑